ABSTRACT
INTRODUCTION
Recent advances in genomic technologies have enabled researchers to conduct large-scale studies of human disease-associated epigenetic variation, specifically variation in DNA methylation. Such epigenome-wide association studies (EWAS) have helped elucidate the non-genetic determinants of human disease (Rakyan et al., 2011) . The Illumina Infinium HumanMethylation450 a These authors made equal contribution to this work * To whom correspondence should be addressed Beadchip, which interrogates the methylation level of more than 450K CpG sites throughout the human genome, has been increasingly popular in large-scale EWAS due to its good genome coverage, high reproducibility and lower cost (Sandoval et al., 2011) . One observation of the 450K data is that many CpGs have relatively larger technical variability compared to their biological variability, which are results of either large absolute technical variability (the methylation level cannot be measured accurately) or lower biological variability (many CpGs are constitutively methylated or unmethylated). These CpGs are less informative and including these CpGs will reduce the statistical power to discover relevant CpG sites by unnecessarily increasing the number of statistical tests. Hence, CpG filtering could potentially boost statistical power for underpowered studies. Traditional variancebased CpG filter is based on the total variability, which is the sum of the biological variability (signal) and technical variability (noise). However, we are more interested in retaining CpGs with relatively large biological variability instead of total variability. As with any hybridization-based array technology, CpG probes differ in their technical variability, possibly due to inexact probe sequence match, cross-hybridization and local secondary structures (Price et al., 2013) . Therefore, large total variability does not necessarily reflect large biological variability. Without technical replicates, the assessment of technical variability is difficult and we can only rely on the total variability to filter CpGs. Fortunately, most EWAS have included some technical replicates to assess various sources of batch effects. We can therefore use these replicates to assess technical variability. We propose to use intra-class correlation coefficient (ICC), which is defined as the ratio of biological variability to total variability, to filter CpG probes (Donner et al., 1980) . We extend technical replicate-based method by Meng et al., 2010 & Bose et al., 2014 and estimate ICC using a linear mixed effects model (LMM) by pooling all samples including the unreplicated ones. Compared to the method using technical replicates only, our method can result in more efficient ICC estimate since the unreplicated samples provide significant amount of information about the biological variability. Our method can accommodate any type of replicate design including unbalanced design. We have implemented an ultrafast algorithm to fit LMM in linear computational time and the algorithm is highly scalable.
MODEL
Suppose we have m independent biological samples measuring the methylation of p CpGs. Assume each biological sample replicates ni(i=1, . . . , m) times, totaling n= m i=1 ni samples. Note in most studies, the majority of the samples are not replicated and the majority of ni=1. Before ICC estimation, we recommend that data normalization and batch correction be performed to remove systematic technical variability. Denote yij as the methylation Mvalue of a given CpG for ith biological sample and its jth technical replicate. We model yij using a linear mixed effects model (LMM)
where ǫij∼N (0, σ 2 ǫ ) and ξi∼N (0, σ 2 ξ ) represent technical and biological variability respectively. Denote yi = (yi1, · · · , yin i ) and
T , we then have
with the mean µ = (µ, µ, · · · , µ) T and the covariance matrix V ) is the intra-class correlation coefficient (ICC). When σ 2 ǫ is the same for all CpGs, the filtering procedure based on the total variance is the same as that based on ICC. However, as in all arraybased technologies, different probes have different measurement error levels and ICC is generally a more appropriate measure than total variance. Fitting a mixed effects model with existing generalpurpose algorithms is computationally intensive and is not scalable with the ever increasing sample size and CpG sites for genomewide association studies. The major contribution of this paper is therefore the development of an ultra-fast algorithm based on maximum likelihood estimation, utilizing the special structure of the covariance matrix (block-diagonality and compound symmetry structure). The computational complexity is O(np) and scalable with the sample size and CpG number. The detailed algorithm is included in the Supplementary Note 1.
RESULTS
We compare our whole-sample ICC method to the replicate-sample ICC method by Bose et al., 2014 as well as the total variancebased method using simulations. We simulate 1,000 CpGs and 1,000 independent samples, among which 10 samples are replicated twice. Let σξ∼Uniform(0.5, 8.0) and σǫ∼Uniform(0.25, 2.0). We then simulate the methylation M-values based on the model (1) and rank these CpGs based on ICC or variance after applying the three alternatives. We calculate the Spearman correlation between the resulted ranking and the ranking based on the simulated true ρ's, which is assumed to be the best. Simulations are repeated 100 times. Fig. 1A shows our whole-sample ICC method produces invariably better ranking than the other two methods ( median correlation 0.80 vs 0.70 and 0.58). We next study the effects of ICC-based CpG filtering on the type I error and power of association tests using realistic simulations (Supplementary Note 2). CpGs with small ICCs will have no, or little chance of showing significance, and removing these CpGs will enrich signals against a background of noise. As expected, using Bonferroni correction and false discovery rate control for multiple comparison correction, the proposed method has achieved better power than the replicatesample ICC method, while controlling the type I error at the desired level. Simulation also suggests at least six technical replicate pairs to achieve good results. We apply our method to a cleaned 450K dataset of 482,985 methylation sites from buffy coat leukocytes of 559 males and 10 technical replicate pairs from the Normative Aging Study (Marioni et al., 2015) . We conduct an epigenome-wide crosssectional analysis of age (median 72, range 55-100 years) based on a linear model, adjusting for subject characteristics, estimated cell type proportions, and technical covariates. Strict Bonferroni correction is used to select 'significant' CpG sites. Clearly, these sites are dramatically enriched in large ICC values ( Figure 1B) . We see that 96.7% of the sites associated with age come from those with an ICC greater than the median (0.55). We also see 138,562 sites with an estimated ICC of zero, indicating much larger technical variability (measurement error) compared to their biological variability. In comparison with the ICC method, if we had only used the sites with total variance above the median, we would have captured only 93% of the sites associated with age in the full analysis (Supplementary Figure S1) . In general, an ICC cutoff of around 0.5 provides a good trade-off between loss of potential significant CpG sites due to filtering and gain of power due to reduction of multiple testing burden (Supplementary Figure S1) .
